RecruitingNeurological/Neurodegenerative · Depression
A Study for Adult Participants With Major Depressive Disorder
Sarnia & Hamilton, Ontario
Depression is a mood disorder, not simply a low patch. It brings low mood, or a loss of interest in things that used to matter, that stays for weeks at a time, and it changes sleep, appetite, energy and concentration along with it. Often the hardest part is that the things which normally help, work, company, being outside, are the first things that get difficult.
Depression is not the same as sadness. The Centre for Addiction and Mental Health describes it as much more than unhappiness. The pattern a clinician looks for is low mood or loss of interest present most of the day, most days, for two weeks or longer, together with changes in sleep, appetite, energy or concentration, and enough interference with daily life that work, school, relationships or looking after yourself are affected.
It is also not a character flaw or a failure of effort. Depression involves genetic, biological, environmental and psychological factors together, and it often sits alongside another illness: a thyroid problem, diabetes, heart disease or long-term pain all raise the risk. Some people have one episode in a lifetime and others have several. In Canada, 14.0% of people aged 15 and older have had a major depressive episode at some point in their lives.
No two people get the same set. Some sleep constantly and others barely sleep; some feel flattened and slowed while others feel agitated. Symptoms also shift over the course of an episode, which is part of why clinicians in Canada use the same short questionnaire at repeat visits rather than relying on one conversation.

Some risk factors cannot be changed:
Others can often be worked on, usually with support from a health care team:
Depression is most often identified by a family doctor or nurse practitioner. They ask about mood, interest, sleep, appetite, energy and concentration, how long the symptoms have lasted, and how much they are affecting work, school, relationships and daily tasks. Short validated questionnaires such as the PHQ-2 and PHQ-9 are commonly used, both to screen and to track change over time, an approach the Canadian Network for Mood and Anxiety Treatments calls measurement-based care. Blood tests are ordered only when a physical cause is suspected, such as a thyroid problem, and brain scans and EEG are not part of a routine assessment. A clinician will also ask about alcohol and drug use, medicines, and any past periods of unusually high mood or energy, because that changes the diagnosis. Some people are referred on to a psychiatrist, psychologist, social worker or a community mental health programme.
Clinical research for Depression is enrolling. See the current studies
Canada has national guidelines for depression, published by the Canadian Network for Mood and Anxiety Treatments and last updated in 2023. They set out several kinds of first-line care rather than one route. Depending on how severe an episode is, what has helped before, and what is available where you live, a health care team may discuss:
Which of these fits depends on the person, and access differs a great deal across the country. These are decisions for you and your own clinician, and this page is not a recommendation about any of them.
Depression is common and Canada has established care pathways for it, but not everyone gets better with the first thing they try, and there is no test that tells a clinician in advance which treatment will suit a particular person. The 2023 Canadian guidelines added a framework for difficult-to-treat depression, in which the focus shifts from clearing every symptom towards the best possible functioning and quality of life, and they note that only about 20% of people with major depressive disorder worldwide receive adequate treatment. In Canada the gap shows up in a specific place: Statistics Canada found counselling to be the least met need, unmet or only partly met for 30.5% of people with a mood, anxiety or substance use disorder, against 7.0% for medication. Studies are currently looking at markers that could match people to treatments sooner, rapid-acting medicines, newer neurostimulation methods, psychological therapies in digital and group formats, treatments aimed at winter-pattern and postpartum depression, and ways of organising care that shorten the wait for therapy.
Clinical studies are how any of that gets tested. Taking part is voluntary, you give informed consent before anything begins, and you can stop at any time without affecting the care you get from your own doctor. Joining a study does not mean giving up your current treatment, and no one can tell in advance whether a study will help you personally.
This page is written in plain language for people considering clinical research. It is general health information, not medical advice, and it does not replace a conversation with your own doctor or nurse practitioner.
Everyone has low days. Depression is different in how long it lasts and how much it takes over. The pattern clinicians look for is low mood or loss of interest present most of the day, most days, for two weeks or more, along with changes in sleep, appetite, energy or concentration, and enough interference with daily life that work, school or relationships are affected. The Centre for Addiction and Mental Health describes depression as much more than unhappiness.
No. Canadian guidelines from the Canadian Network for Mood and Anxiety Treatments set out several kinds of first-line care, including psychological treatments such as cognitive behavioural therapy, behavioural activation and interpersonal therapy, along with antidepressant medicines. They also cover physical activity, sleep, light therapy for winter-pattern depression, guided digital programmes and neurostimulation. Which of these fits depends on the person, how severe the episode is, and what is available where you live. That is a conversation for you and your own clinician.
Because a lot is still unknown. Trials are how researchers find out whether a new medicine, therapy, digital programme or stimulation method helps, and how it compares with current care. Taking part usually means extra assessments and closer monitoring by a research team. Participation is voluntary, you give informed consent before anything starts, and you can withdraw at any time without affecting the care you get from your own doctor. No one can say in advance whether a study will help you personally.
RecruitingNeurological/Neurodegenerative · Depression
Sarnia & Hamilton, Ontario